What is Zacks Research’s Estimate for EMN Q1 Earnings?

Eastman Chemical Company (NYSE:EMNFree Report) – Investment analysts at Zacks Research boosted their Q1 2026 earnings per share estimates for shares of Eastman Chemical in a note issued to investors on Wednesday, February 11th. Zacks Research analyst Team now forecasts that the basic materials company will earn $1.20 per share for the quarter, up from their previous forecast of $1.15. The consensus estimate for Eastman Chemical’s current full-year earnings is $8.55 per share. Zacks Research also issued estimates for Eastman Chemical’s Q2 2026 earnings at $1.62 EPS, Q3 2026 earnings at $1.68 EPS, Q4 2026 earnings at $1.39 EPS, FY2026 earnings at $5.89 EPS, Q1 2027 earnings at $1.64 EPS, Q2 2027 earnings at $1.66 EPS, Q3 2027 earnings at $1.69 EPS, Q4 2027 earnings at $1.74 EPS, FY2027 earnings at $6.73 EPS and FY2028 earnings at $7.51 EPS.

Eastman Chemical (NYSE:EMNGet Free Report) last issued its earnings results on Thursday, January 29th. The basic materials company reported $0.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.01). The company had revenue of $1.97 billion for the quarter, compared to analysts’ expectations of $2.03 billion. Eastman Chemical had a net margin of 5.42% and a return on equity of 10.63%. The firm’s revenue for the quarter was down 12.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.87 earnings per share.

Several other analysts also recently weighed in on EMN. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $79.00 price target on shares of Eastman Chemical in a research note on Wednesday, February 4th. JPMorgan Chase & Co. lifted their target price on Eastman Chemical from $60.00 to $70.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. KeyCorp reiterated an “overweight” rating on shares of Eastman Chemical in a report on Monday, February 2nd. Bank of America raised their price target on Eastman Chemical from $74.00 to $79.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Finally, Evercore lowered their price objective on shares of Eastman Chemical from $75.00 to $70.00 and set an “in-line” rating for the company in a research note on Tuesday, November 11th. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Eastman Chemical currently has an average rating of “Hold” and a consensus target price of $78.86.

View Our Latest Stock Report on Eastman Chemical

Eastman Chemical Price Performance

Eastman Chemical stock opened at $79.87 on Thursday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.76 and a quick ratio of 0.86. The stock has a market cap of $9.11 billion, a price-to-earnings ratio of 19.53, a price-to-earnings-growth ratio of 1.79 and a beta of 1.23. The firm has a 50-day moving average of $68.03 and a two-hundred day moving average of $65.15. Eastman Chemical has a 1 year low of $56.11 and a 1 year high of $103.82.

Institutional Trading of Eastman Chemical

A number of institutional investors have recently made changes to their positions in the business. Brighton Jones LLC purchased a new stake in Eastman Chemical in the fourth quarter valued at about $202,000. Integrated Wealth Concepts LLC increased its holdings in shares of Eastman Chemical by 185.6% during the first quarter. Integrated Wealth Concepts LLC now owns 6,686 shares of the basic materials company’s stock valued at $589,000 after acquiring an additional 4,345 shares in the last quarter. Millennium Management LLC raised its position in shares of Eastman Chemical by 69.2% in the 1st quarter. Millennium Management LLC now owns 194,052 shares of the basic materials company’s stock valued at $17,098,000 after purchasing an additional 79,376 shares during the last quarter. NewEdge Advisors LLC raised its position in shares of Eastman Chemical by 2.6% in the 1st quarter. NewEdge Advisors LLC now owns 7,310 shares of the basic materials company’s stock valued at $644,000 after purchasing an additional 183 shares during the last quarter. Finally, United Services Automobile Association acquired a new stake in Eastman Chemical in the 1st quarter worth approximately $252,000. Institutional investors and hedge funds own 83.65% of the company’s stock.

Eastman Chemical Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, January 8th. Stockholders of record on Monday, December 15th were given a dividend of $0.84 per share. The ex-dividend date of this dividend was Monday, December 15th. This is a boost from Eastman Chemical’s previous quarterly dividend of $0.83. This represents a $3.36 dividend on an annualized basis and a dividend yield of 4.2%. Eastman Chemical’s payout ratio is currently 82.15%.

More Eastman Chemical News

Here are the key news stories impacting Eastman Chemical this week:

  • Positive Sentiment: Zacks raised Q1 2026 EPS to $1.20 from $1.15 (small beat vs prior) — a modest near‑term improvement that could support upcoming quarter sentiment.
  • Positive Sentiment: Zacks also nudged Q2 2026 EPS up to $1.62 from $1.59, indicating slightly stronger expectations for spring demand/volume versus prior assumptions.
  • Neutral Sentiment: Zacks published a longer‑range FY2028 estimate of $7.51 EPS (informative but farther out and subject to change).
  • Neutral Sentiment: Technical/market note: a recent MSN piece highlights rising relative strength in EMN but says the stock remains below a key threshold — positive technical momentum but not yet a breakout. Article Title
  • Negative Sentiment: Zacks cut FY2026 EPS to $5.89 from $6.01 — a meaningful downward revision that lowers near‑term earnings power versus prior expectations.
  • Negative Sentiment: Zacks trimmed FY2027 EPS to $6.73 from $7.31, reducing multi‑year growth expectations and implying slower recovery than investors may have hoped.
  • Negative Sentiment: Multiple quarter-level downgrades across 2026–2027: Q4 2026 to $1.39 (from $1.51), Q1–Q4 2027 cuts (Q1 2027 to $1.64 from $1.75; Q2 2027 to $1.66 from $1.75; Q3 2027 to $1.69 from $1.89; Q4 2027 to $1.74 from $1.92). These sequential cuts suggest Zacks sees weaker volumes/margins or slower end‑market recovery.

About Eastman Chemical

(Get Free Report)

Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.

See Also

Earnings History and Estimates for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.